Rapid, Accurate Test to Diagnose CJD Developed

Researchers have developed a highly sensitive assay for early diagnosis of the degenerative neurological condition Creutzfeldt-Jakob Disease (CJD).

Researchers have developed a highly sensitive assay for early diagnosis of the degenerative neurological condition Creutzfeldt-Jakob Disease (CJD). The assay has been developed by microbiologist Ryuichiro Atarashi of Nagasaki University, Japan, and his team.

CJD is a prion disease, in which an isomer of a common protein known as the prion protein (PrP) takes on an abnormal shape and becomes an infectious variant called PrPSc. This variant is thought to trigger the subsequent malformation of other PrP proteins. Unlike their normal counterparts, PrPSc prions cannot be broken down, and instead accumulate - often clustering in brain tissue.

Man Who Died from CJD Had Different Genetic Variant
Professor John Collinge, of the National Prion Clinic, and colleagues have revealed that a man who died in January from variant CJD had a different gene

The pockets of abnormal tissue that result cause brain tissue to develop a sponge-like appearance, and because prion conditions can be spread by affected humans or animals, the diseases are often referred to as transmissible spongiform encephalopathies (TSEs).

One problem that has plagued developers of non-biopsy diagnostic techniques is that it is often difficult to avoid false positives among samples taken from patients with neurodegenerative disorders other than CJD.

So Atarashi and his colleagues used a new assay known as a real-time quaking-induced conversion (RT-QUIC) assay. 'Quaking-induced' refers to in vitro shaking, which researchers believe helps to accelerate the reactions, enabling the assay to produce results more quickly.

Study Says Prevalence of Variant CJD Agent in Britain is Unclear
A large tissue survey in Britain of the agent that causes variant Creutzfeldt-Jakob disease (vCJD) are unable to establish if the prevalence is lower than that given by previous estimates

The team tested cerebrospinal fluid samples from 18 people with CJD and 35 people with other neurodegenerative diseases. This pilot group produced no false positives, and CJD was correctly diagnosed more than 83 pc of the time.

"This technique allows definitive ante-mortem confirmation of CJD," Nature quoted Atarashi, who added that this is currently difficult because it demands the detection of PrPSc in patients' biopsy specimens, as saying.

Breakthrough Research Finds Gene Clue To 130 Brain Diseases
Scientists on Sunday said they had discovered a bouquet of proteins that play a critical role in the development of more than 130 brain diseases.

The findings have been published online in Nature Medicine.

Source-ANI

Protein Protects Neurons in Brain from Damage Due to Inflammation
A research team from the University of California, San Diego School of Medicine and the Salk Institute for Biological Studies in La Jolla has identified a protein in the brain of mice